VIREAD 33 mg/g, granulés

( ARTG ) VIREAD in combination with other antiretroviral agents is indicated for the treatment of HIV-infected adults and paediatric patients 12 years of age and older.,VIREAD is indicated for the treatment of chronic hepatitis B in adults (see CLINICAL TRIALS).,VIREA‍‍‍‍‍‍​​​‍​​​​​​D is indicated for the treatment of chronic hepatitis B in paediatric patients 12 years of age and older with compensated liver disease and with evidence of immune active disease, i.e. active viral replication, persistently elevated serum ALT levels or evidence of active inflammation.VIREAD in combination with other antiretroviral agents is indicated for the treatment of HIV-infected adults. VIREAD is indicated for the treatment of chronic hepatitis B in adults with evidence of active viral replication and active liver inflammation.